Boston Scientific Corporation logo BSX - Boston Scientific Corporation

NEXT EARNINGS: Feb 4, 2026 (in 0 days)
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
2
BUY 38
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $121.31 DETAILS
HIGH: $140.00
LOW: $100.00
MEDIAN: $124.00
CONSENSUS: $121.31
UPSIDE: 55.43%
Market Cap: 115.75B
Volume: 50,899,654
Avg Volume: 10,454,860
52 Week Range: 75-109.5
Sector: Healthcare
Industry: Medical - Devices
Beta: 0.66
Last Dividend: $N/A
Exchange: NYSE
Country: US
Employees: 53,000
IPO Date: 1992-05-19
EPS (TTM): 1.26
P/E Ratio: 70.89
Revenue (TTM): 16.75B
Total Assets: 39.40B
Total Debt: 11.15B
Cash & Equiv: 414.00M
Rev Growth (5Y): 9.3%
EPS Growth (5Y): -17.9%
FCF Growth (5Y): 14.0%
ROCE: 8.1%
Debt/Equity: 0.51

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 16.75B 14.24B 12.68B 11.89B 9.91B 10.73B 9.82B 9.05B 8.39B 7.48B 7.38B 7.14B
Net Income 1.85B 1.59B 698.00M 1.04B (82.00M) 4.70B 1.67B 104.00M 347.00M (239.00M) (119.00M) (121.00M)
EPS 1.26 1.08 0.45 0.69 -0.08 3.38 1.21 0.08 0.26 -0.18 -0.09 -0.09
Total Assets 39.40B 35.14B 32.47B 32.23B 30.78B 30.57B 21.00B 19.04B 18.10B 18.13B 16.83B 16.73B
Total Debt 11.15B 9.49B 9.28B 9.45B 9.54B 10.28B 7.03B 5.58B 5.48B 5.68B 4.26B 4.24B
Cash & Equivalents 414.00M 865.00M 928.00M 1.93B 1.73B 217.00M 146.00M 188.00M 196.00M 319.00M 587.00M 217.00M
Operating Cash Flow 3.44B 2.50B 1.53B 1.87B 1.51B 1.84B 310.00M 1.43B 972.00M 600.00M 1.27B 1.08B
Free Cash Flow 2.65B 1.70B 914.00M 1.32B 1.13B 1.38B (6.00M) 1.11B 596.00M 353.00M 1.01B 837.00M
FCF per Share 1.80 1.17 0.64 0.93 0.80 0.99 -0.00 0.81 0.44 0.27 0.76 0.62
Book Value 21.77B 19.28B 17.57B 16.62B 15.33B 13.88B 8.72B 7.01B 6.73B 6.32B 6.84B 6.54B
Cash & ST Investments 414.00M 865.00M 928.00M 1.93B 1.73B 217.00M 146.00M 188.00M 196.00M 319.00M 587.00M 217.00M
ROC Equity 0.09 0.08 0.04 0.06 -0.01 0.34 0.19 0.01 0.05 -0.04 -0.02 -0.02